102 related articles for article (PubMed ID: 21848413)
21. Predictors of bleeding and user satisfaction during consecutive use of the levonorgestrel-releasing intrauterine system.
Heikinheimo O; Inki P; Kunz M; Gemzell-Danielsson K
Hum Reprod; 2010 Jun; 25(6):1423-7. PubMed ID: 20378611
[TBL] [Abstract][Full Text] [Related]
22. Compliance and user satisfaction with the intra-uterine contraceptive device in Family Planning Service: the results of a survey in Fife, Scotland, August 2004.
Tewari R; Kay VJ
Eur J Contracept Reprod Health Care; 2006 Mar; 11(1):28-37. PubMed ID: 16546814
[TBL] [Abstract][Full Text] [Related]
23. Patient satisfaction with a levonorgestrel-releasing contraceptive implant. Reasons for and patterns of removal.
Haugen MM; Evans CB; Kim MH
J Reprod Med; 1996 Nov; 41(11):849-54. PubMed ID: 8951137
[TBL] [Abstract][Full Text] [Related]
24. Levonorgestrel-releasing intrauterine system for treating menstrual disorders: a patient satisfaction questionnaire.
Radesic B; Sharma A
Aust N Z J Obstet Gynaecol; 2004 Jun; 44(3):247-51. PubMed ID: 15191451
[TBL] [Abstract][Full Text] [Related]
25. Health effects of long-term use of the intrauterine levonorgestrel-releasing system. A follow-up study over 12 years of continuous use.
Rönnerdag M; Odlind V
Acta Obstet Gynecol Scand; 1999 Sep; 78(8):716-21. PubMed ID: 10468065
[TBL] [Abstract][Full Text] [Related]
26. [Clinical study on women with amenorrhea after levonorgestrel intrauterine system].
Zhang L; Weng L
Zhonghua Fu Chan Ke Za Zhi; 2001 Nov; 36(11):675-7. PubMed ID: 11930695
[TBL] [Abstract][Full Text] [Related]
27. Immediate versus delayed insertion of the levonorgestrel-releasing intrauterine device following dilation and evacuation: a randomized controlled trial.
Hohmann HL; Reeves MF; Chen BA; Perriera LK; Hayes JL; Creinin MD
Contraception; 2012 Mar; 85(3):240-5. PubMed ID: 22067762
[TBL] [Abstract][Full Text] [Related]
28. The Femilis LNG-IUS: contraceptive performance-an interim analysis.
Wildemeersch D; Janssens D; Andrade A
Eur J Contracept Reprod Health Care; 2009 Apr; 14(2):103-10. PubMed ID: 19340705
[TBL] [Abstract][Full Text] [Related]
29. Assessment of menstrual blood loss in Belgian users of a new T-shaped levonorgestrel-releasing intrauterine system.
Wildemeersch D; Rowe PJ
Contraception; 2005 Jun; 71(6):470-3. PubMed ID: 15914139
[TBL] [Abstract][Full Text] [Related]
30. Subject and clinician experience with the levonorgestrel-releasing intrauterine system.
Jensen JT; Nelson AL; Costales AC
Contraception; 2008 Jan; 77(1):22-9. PubMed ID: 18082662
[TBL] [Abstract][Full Text] [Related]
31. Endometrial morphology during hormone replacement therapy with estradiol gel combined to levonorgestrel-releasing intrauterine device or natural progesterone.
Suvanto-Luukkonen E; Malinen H; Sundström H; Penttinen J; Kauppila A
Acta Obstet Gynecol Scand; 1998 Aug; 77(7):758-63. PubMed ID: 9740525
[TBL] [Abstract][Full Text] [Related]
32. Levonorgestrel-releasing intrauterine device versus hysteroscopic endometrial resection in the treatment of dysfunctional uterine bleeding.
Crosignani PG; Vercellini P; Mosconi P; Oldani S; Cortesi I; De Giorgi O
Obstet Gynecol; 1997 Aug; 90(2):257-63. PubMed ID: 9241305
[TBL] [Abstract][Full Text] [Related]
33. Uterine volume and menstrual patterns in users of the levonorgestrel-releasing intrauterine system with idiopathic menorrhagia or menorrhagia due to leiomyomas.
Magalhães J; Aldrighi JM; de Lima GR
Contraception; 2007 Mar; 75(3):193-8. PubMed ID: 17303488
[TBL] [Abstract][Full Text] [Related]
34. A cross-sectional study of the forearm bone density of long-term users of levonorgestrel-releasing intrauterine system.
Bahamondes L; Espejo-Arce X; Hidalgo MM; Hidalgo-Regina C; Teatin-Juliato C; Petta CA
Hum Reprod; 2006 May; 21(5):1316-9. PubMed ID: 16373404
[TBL] [Abstract][Full Text] [Related]
35. Menstrual blood loss in women using the frameless FibroPlant LNG-IUS.
Andrade A; Wildemeersch D
Contraception; 2009 Feb; 79(2):134-8. PubMed ID: 19135571
[TBL] [Abstract][Full Text] [Related]
36. Comparison of metabolic and inflammatory outcomes in women who used oral contraceptives and the levonorgestrel-releasing intrauterine device in a general population.
Morin-Papunen L; Martikainen H; McCarthy MI; Franks S; Sovio U; Hartikainen AL; Ruokonen A; Leinonen M; Laitinen J; Järvelin MR; Pouta A
Am J Obstet Gynecol; 2008 Nov; 199(5):529.e1-529.e10. PubMed ID: 18533124
[TBL] [Abstract][Full Text] [Related]
37. The levonorgestrel intrauterine system is an effective treatment in selected obese women with abnormal uterine bleeding.
Vilos GA; Marks J; Tureanu V; Abu-Rafea B; Vilos AG
J Minim Invasive Gynecol; 2011; 18(1):75-80. PubMed ID: 21195957
[TBL] [Abstract][Full Text] [Related]
38. The levonorgestrel intrauterine system in nulliparous women.
Prager S; Darney PD
Contraception; 2007 Jun; 75(6 Suppl):S12-5. PubMed ID: 17531602
[TBL] [Abstract][Full Text] [Related]
39. [Acceptability of intrauterine levonorgestrel delivery system (Mirena 52mg) after estrogen-progesterone oral contraception: results of a prospective multicentric study of 211 patients aged 25-35 years].
Collinet P; Nayama M; Cosson M
J Gynecol Obstet Biol Reprod (Paris); 2006 Dec; 35(8 Pt 1):778-84. PubMed ID: 17151533
[TBL] [Abstract][Full Text] [Related]
40. Treatment of dysfunctional uterine bleeding: patient preferences for endometrial ablation, a levonorgestrel-releasing intrauterine device, or hysterectomy.
Bourdrez P; Bongers MY; Mol BW
Fertil Steril; 2004 Jul; 82(1):160-6, quiz 265. PubMed ID: 15237006
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
